Education
About Us
Working with TipRanks
Follow Us
Gossamer Bio Inc (GOSS)
NASDAQ:GOSS
Total Valuation
Gossamer Bio has a market cap or net worth of $188.00M. The enterprise value is $113.35M.
Market Cap$188.00M
Enterprise Value$113.35M
Share Statistics
Gossamer Bio has 227,221,270 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding227,221,270
Owned by Insiders9.39%
Owned by Institutions0.02%
Financial Efficiency
Gossamer Bio’s return on equity (ROE) is -1.92 and return on invested capital (ROIC) is -22.45%.
Return on Equity (ROE)-1.92
Return on Assets (ROA)-0.18
Return on Invested Capital (ROIC)-22.45%
Return on Capital Employed (ROCE)-0.22
Revenue Per Employee796.53K
Profits Per Employee-392.56K
Employee Count144
Asset Turnover0.36
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Gossamer Bio is -3.62. Gossamer Bio’s PEG ratio is 0.05.
PE Ratio-3.62
PS Ratio2.75
PB Ratio6.94
Price to Fair Value6.94
Price to FCF-59.01
Price to Operating Cash Flow-59.01
PEG Ratio0.05
Income Statement
In the last 12 months, Gossamer Bio had revenue of 114.70M and earned -56.53M in profits. Earnings per share was -0.25.
Revenue114.70M
Gross Profit114.70M
Operating Income-59.92M
Pretax Income-55.63M
Net Income-56.53M
EBITDA-39.97M
Earnings Per Share (EPS)-0.25
Cash Flow
In the last 12 months, operating cash flow was -3.47M and capital expenditures 0.00, giving a free cash flow of -119.82M billion.
Operating Cash Flow-3.47M
Free Cash Flow-119.82M
Free Cash Flow per Share-0.53
Dividends & Yields
Gossamer Bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.17
52-Week Price Change25.35%
50-Day Moving Average1.14
200-Day Moving Average0.98
Relative Strength Index (RSI)43.47
Average Volume (3m)1.57M
Important Dates
Gossamer Bio upcoming earnings date is May 13, 2025, TBA Not Confirmed.
Last Earnings DateMar 13, 2025
Next Earnings DateMay 13, 2025
Ex-Dividend Date―
Financial Position
Gossamer Bio as a current ratio of 6.88, with Debt / Equity ratio of 687.92%
Current Ratio6.88
Quick Ratio6.88
Debt to Market Cap0.99
Net Debt to EBITDA-3.92
Interest Coverage Ratio-5.20
Taxes
In the past 12 months, Gossamer Bio has paid 893.00K in taxes.
Income Tax893.00K
Effective Tax Rate-0.02
Enterprise Valuation
Gossamer Bio EV to EBITDA ratio is -9.04, with an EV/FCF ratio of -104.23.
EV to Sales3.15
EV to EBITDA-9.04
EV to Free Cash Flow-104.23
EV to Operating Cash Flow-104.23
Balance Sheet
Gossamer Bio has $294.52M in cash and marketable securities with $6.04M in debt, giving a net cash position of -$91.64M billion.
Cash & Marketable Securities$294.52M
Total Debt$6.04M
Net Cash-$91.64M
Net Cash Per Share-$0.40
Tangible Book Value Per Share$0.13
Margins
Gross margin is 98.28%, with operating margin of -52.24%, and net profit margin of -49.28%.
Gross Margin98.28%
Operating Margin-52.24%
Pretax Margin-48.50%
Net Profit Margin-49.28%
EBITDA Margin-34.84%
EBIT Margin-38.46%
Analyst Forecast
The average price target for Gossamer Bio is $8.75, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$8.75
Price Target Upside883.15% Upside
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast―
EPS Growth Forecast81.94%